D'après la communication de : Raffaele Scarpa, Francesco Manguso, Alfonso Oriente, Rosario Peluso, Pasquale Oriente Naples, NA, Italy [Abstract 239] LEFLUNOMIDE IN PSORIATIC POLYARTHRITIS: AN ITALIAN PILOT STUDY. Rapporté par Philippe Brissaud, Paris

D'après la communication de : John D Carter, Charles R Mills, Joanne Valeriano-Marcet, Keith S Kanik, Frank B Vasey Tampa, FL [Abstract 235] PRELIMINARY 6 MONTH RESULTS OF A PROSPECTIVE COMPARISON OF DOXYCYCLINE VS. DOXYCYCLINE AND RIFAMPIN IN UNDIFFERENTIATED SPONDYLOARTHRITIS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Marjatta Leirisalo-Repo, Leena Paimela, Heikki Julkunen, Ritva Peltomaa, Kirsi Laasila, Hannu Kautiainen, Heikki Repo Heinola, Helsinki and Vantaa, Finland (Abstract 234] A 3-MONTH, RANDOMISED, PLACEBO-CONTROLLED STUDY WITH COMBINATION ANTIMICROBIAL THERAPY IN ACUTE REACTIVE ARTHRITIS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Jeffrey Madwed, Carina L Bos, Abhya Gupta, Stephen H Polmar, Dariusz P Olszyna, C Erik Hack, Sander JH van Deventer, Maikel P Peppelenbosch, Tom van der Poll Amsterdam, The Netherlands; Ridgefield, CT; Biberach, Germany [Abstract 671] ANTI-INFLAMMATORY EFFECTS OF A P38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR (BIRB 796 BS) DURING HUMAN ENDOTOXEMIA. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Astrid Hirth, Jorg Distler, Reinhart Seibl, Ulf Muller-Ladner, Beat A Michel, Renate E Gay, Jochen R Kalden, Frank Emmrich, Hannes M Lorenz, Steffen Gay, Oliver Distler Switzerland; Germany [Abstract 668] INTERLEUKIN 21 RECEPTOR IS EXPRESSED IN SYNOVIAL LINING CELLS OF PATIENTS WITH RHEUMATOID ARTHRITIS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Alice B Gottlieb, Akshay K Vaishnaw New Brunswick, NJ and Cambridge, MA [Abstract 232] ALEFACEPT (AMEVIVE™) DOES NOT BLUNT PRIMARY OR SECONDARY IMMUNE RESPONSES. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Huibert J Dinant, Arno WR van Kuijk, Amber Y Goedkoop, Maarten C Kraan, Menno A de Rie, Ben AC Dijkmans, Akshay Vaishnaw, Paul P Tak Amsterdam, Netherlands; Cambridge, MA [Abstract 233] ALEFACEPT (LFA3-IgG1 FUSION PROTEIN, LFA3TIP) REDUCES SYNOVIAL INFAMMATORY INFILTRATE AND IMPROVES OUTCOME IN PSORIATIC ARTHRITIS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Nicole Amft, Simon J Bowman, S John Curnow, Dagmar Scheel-Toellner, Jane Oates, John Crocker, John Hamburger, John Matthews, Mike Salmon, Christopher D Buckley Birmingham, United Kingdom [Abstract 666] CONSTITUTIVE CHEMOKINE AND CHEMOKINE RECEPTOR EXPRESSION CONTRIBUTES TO THE PATTERN OF INFLAMMATORY CELL INFILTRATES IN SJOGREN'S SYNDROME. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Maria Teresa Carulli, Mark C Blades, Smaira Wahid, Francesca Ingegnoli, Ghada Yanni, Oliver Fitzgerald, Barry Bresnihan, Gabriel S Panayi, Mariagrazia Uguccioni, Costantino Pitzalis London, United Kingdom; Dublin, Ireland and Bellinzona, Switzerland [Abstract 665] BCA-1 CHEMOKINE (CK) IS INSTRUMENTAL IN THE ORGANIZATION OF LYMPHOID AGGREGATES IN RHEUMATOID ARTHRITIS (RA). Rapporté par Philippe Brissaud, Paris

D'après la communication de : Frederick Wolfe, Barbara Stephenson, Joseph Doyle Wichita, KS and Bridgewater, NJ [Abstract 547] RA PATIENTS REMAIN ON LEFLUNOMIDE AS LONG AS METHOTREXATE IN CLINICAL PRACTICE: ACCUMULATING EVIDENCE OF LONG-TERM TOLERABILITY AND EFFECTIVENESS OF LEFLUNOMIDE IN RA Rapporté par Philippe Brissaud, Paris

D'après la communication de Xavier Ayral, Eve H Pickering, Thasia G Woodworth, Neil Mackillop, Maxime Dougados Paris ; Groton and Sandwich, United Kingdom. (Abstract 291) Synovitis predicts the arthroscopic progression of medial tibiofemoral knee osteoarthritis Rapporté par Philippe Brissaud

D'après la communication de : Akiko Aoki, Eri Hagiwara, Shigeru Ohno, Astuhisa Ueda, Yoshiyuki Kuroiwa, Yume Suzuki, Hidetake Miyazaki, Ichiro Aoki, Yoshiaki Ishigatsubo Yokohama, Kanagawa, Japan [Abstract 538] MYOSITIS IN PRIMARY SJOGREN'S SYNDROME CLINICAL, IMMUNOLOGICAL AND PATHOLOGICAL REPORT. Rapporté par Philippe Brissaud, Paris